Gamma Vitamin E Supplement Market

Gamma Vitamin E Supplement Market Outlook (2024 to 2034)

Revenue from the global gamma vitamin E supplement market is expected to reach US$ 2.3 billion in 2024 and thereafter increase at a CAGR of 5.3% to climb to US$ 3.8 billion by the end of 2034.

Gamma vitamin E helps lower bad cholesterol levels in the body, which reduces a person's risk of stroke and other cardiovascular conditions such as coronary heart disease. Cancer and cardiovascular diseases remain the leading causes of death worldwide.

• Approximately 18 million deaths worldwide, or 31% of all deaths, are attributed to cardiovascular diseases each year, according to the World Health Organization.
• According to estimates from the World Heart Federation, cardiovascular disease will be a factor in about 22 million deaths by 2030.
• The National Cancer Institute reported that there were approximately 18 million new cases and 9.5 million cancer-related deaths in 2018 due to the disease's high incidence rate. By 2040, this figure is projected to rise to about 28 million new cases and 15 million deaths.

Key Market Growth Drivers

• To enhance the bioavailability and efficacy of gamma vitamin E supplements, ongoing research and development efforts are exploring innovative formulations and delivery methods.
• The focus on niche markets, including athletes, the elderly, and individuals with specific medical conditions, is broadening the utilization and market penetration of gamma vitamin E supplements.
• Establishing strategic partnerships and collaborating with healthcare professionals to raise consumer awareness regarding the benefits of gamma vitamin E supplements is a key strategy.
• Expanding into developing countries and developing countries with increasing populations and a growing focus on wellness and nutritional supplementation are contributing to the expansion of the gamma vitamin E supplement market size.
• Gamma vitamin E offers a range of health benefits, including anti-aging, anti-inflammatory, and cancer-preventive properties, as well as cardioprotective effects. By reducing arterial plaque buildup, gamma vitamin E helps safeguard the heart, making it particularly a preferred choice among people with cardiovascular conditions.
• The global market for gamma vitamin E supplements is projected to exhibit steady growth, driven by rising consumer awareness of the health advantages associated with gamma-tocopherol. This growth is further supported by expanding applications of this vitamin in the food and pharmaceutical industries, increasing demand for dietary supplements, and a growing health-conscious population.

Report Attributes	Details
Gamma Vitamin E Supplement Market Size (2024E)	US$ 2.3 Billion
Forecasted Market Value (2034F)	US$ 3.8 Billion
Global Market Growth Rate (2024 to 2034)	5.3% CAGR
North America Market Value (2024E)	US$ 600 Million
East Asia Market Value (2034F)	US$ 1 Billion
Sales of Gamma Vitamin E Tablets (2024E)	US$ 700 Million
Key Companies Profiled	Pfizer Inc.; Good Health New Zealand; NOW Foods; Abbott; Amway Corp.; Glaxo SmithKline Plc.; Herbalife Nutrition; Bayer AG; Glanbia Plc.; The Nature’s Bounty

What are the Key Factors Driving Consumption of Gamma Vitamin E Supplements?

“Need for Vitamin E Among Infants on Formula Diet Due to High Intake of Polyunsaturated Fats”

People with rheumatoid arthritis and asthma are benefitting from the anti-inflammatory properties of gamma vitamin E, which effectively reduces inflammation. Vitamin E deficiency is prevalent among infants who consume formula, which lacks adequate vitamin E fortification, while a high intake of polyunsaturated fats can increase the need for vitamin E. To enhance the antioxidant capabilities and effectiveness of their supplements, some manufacturers are focusing on developing gamma vitamin E formulations.

Vitamin E comprises a group of fat-soluble compounds with antioxidant properties. Alpha-tocopherol, beta-tocopherol, gamma-tocopherol, and delta-tocopherol are the primary forms. Gamma-tocopherol, in particular, combines with other antioxidants like vitamin C, selenium, and polyphenols, to form a potent antioxidant with complementary mechanisms of action. This effect provides effective antioxidant support, thereby improving overall health and driving demand for gamma vitamin E supplements.

Gamma-tocopherol has unique anti-inflammatory properties that set it apart from other vitamin E forms. It offers improved protection against oxidative stress by scavenging a broader range of reactive nitrogen oxide species. This property plays a crucial role in reducing the risk of chronic diseases such as cancer, heart disease, and neurological disorders.

Which Barriers are Hindering Gamma Vitamin E Supplement Market Growth?

“Safety Concerns Related to Excessive Vitamin E Supplementation”

Vitamin E supplements rarely cause harm when consumed at the recommended daily dose; however, there is a higher risk of hemorrhagic stroke if one takes vitamin E in amounts higher than the recommended daily allowance of 300 IUs.

According to a study by the BMJ, vitamin E increases the risk of hemorrhagic stroke by 22%, so it is not recommended to take supplements of this vitamin.

Factors such as fierce competition among market players, rapid technological advancements, and the need to adapt to shifting consumer demands are contributing to obstacles in this market.

Country-wise Insights

Sales of gamma vitamin E supplements in North America are poised to reach a market value of US$ 600 million in 2024. By 2034, the North American market is projected to reach US$ 1 billion. Through 2034, the market in North America is forecasted to expand at a CAGR of 5.3%.

North America has a significant prevalence of cardiovascular disease and cancer, both leading causes of death in the region. Along with cancer, heart conditions like coronary artery disease also take a heavy toll on lives in the region each year. Given these major health challenges, there is an increasing demand for gamma vitamin E supplements in the region.

What is Prompting Extensive Adoption of Gamma Vitamin E Supplements in the United States?

“Rising Cases of Deaths from Heart Disease Due to Poor Lifestyle Choices”

Attribute	United States
Market Value (2024E)	US$ 400 Million
Growth Rate (2024 to 2034)	4.5% CAGR
Projected Value (2034F)	US$ 700 Million

The United States will hold 74.2% of the gamma vitamin E supplement market share in the North American region in 2024. In the United States, deaths from heart disease are on the rise due to poor lifestyle choices and excessive alcohol consumption, which also contribute to high rates of cancer and cardiovascular diseases. Consumers are looking for solutions to enhance their health. The increasing awareness of the benefits of these supplements is projected to contribute to market growth during the forecast period.

Which Gamma Vitamin E Supplement Market Trends are Worth Following in China?

“Rising Cancer Cases Prompting Adoption of Gamma Vitamin E Supplements as Preventive Measure”

Attribute	China
Market Value (2024E)	US$ 400 Million
Growth Rate (2024 to 2034)	6% CAGR
Projected Value (2034F)	US$ 700 Million

China is estimated to account for a 70.2% share in East Asia in 2024.

• According to the International Agency for Research on Cancer (IARC), approximately 4.5 million Chinese people have been diagnosed with cancer. It is estimated that 5.8 million adult individuals are projected to develop cancer by 2030. Cancer was the cause of about 3 million deaths in the nation, and by 2030, it is expected to claim the lives of about 1 million adults. Due to such concerning figures, consumers in the country are more likely to take supplements, such as gamma vitamin E supplements, to fight against these illnesses.

Category-wise Insights

The gamma vitamin E supplement market, based on form, is segmented into tablets, soft gel, capsules, powder, and gummies, accounting for 32%, 25.9%, and 21.7% market shares, respectively. In terms of sales channel, the market is classified into offline and online modes. The online segment is estimated to account for a 54.1% share of the market in 2024.

What is Contributing to High Preference for Gamma Vitamin E Supplement Tablets?

“Affordability and Longer Shelf Life of Tablet Supplements”

Attribute	Tablets
Segment Value (2024E)	US 700 Million
Growth Rate (2024E)	5.2% CAGR
Projected Value (2034F)	US$ 1.2 Billion

Sales of gamma vitamin E tablets are projected to rise at a CAGR of 5.2% from 2024 to 2034. Tablets are the dominant form of gamma vitamin E supplements, accounting for a 32% market share in 2024. This preference is driven by factors such as affordability and longer shelf life, making vitamin supplements in tablet form a popular choice among consumers.

Which Distribution Channel Accounts for Significant Sales of Gamma Vitamin E Supplements?

“Online Sales of Supplements Gaining Traction Due to Convenience of Ordering from Home”

Attribute	Online
Segment Value (2024E)	US$ 1.2 Billion
Growth Rate (2024E)	5.1% CAGR
Projected Value (2034F)	US$ 2.1 Billion

The online segment is estimated to account for a significant market share of 54.1% in 2024. With the increasing global adoption of smartphones, online sales platforms offer users a wide array of options and the convenience of ordering from their homes.

Competitive Landscape

Key players in the gamma vitamin E supplement industry are The Nature’s Bounty, Pfizer Inc., Good Health New Zealand, NOW Foods, Abbott, Amway Corp., Glaxo SmithKline Plc., Herbalife Nutrition, Bayer AG, and Glanbia Plc.

• Gamma-tocopherol, the gamma form of naturally occurring fat-soluble vitamin E, has been shown in a study published in BMC Complementary Medicine and Therapies to significantly reduce the number of PMS symptoms, such as fatigue, irritability, and water retention.

Key Segments of Gamma Vitamin E Supplement Market Research

• By Form:

  • Tablets
  • Softgel
  • Capsules
  • Powder
  • Gummies

• By Sales Channel:

  • Online
  • Offline

• By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)